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Listeria monocytogenes is a very common intra­
cellular Gram­positive coccobacillus occurring in 
the soil, and humans may be affected via the oral 
route from contaminated food. The organism has 
a remarkable resistance to eradication during food 
processing, has unique virulence factors,[1,2] and is an important cause 
of food­borne epidemic disease with high associated mortality.[3] 
Following ingestion, infection occurs across the intestinal epithelium 
and spreads to the liver, where it becomes established within the 
cytosol of macrophages. Macrophages may then traffic infection via 
the bloodstream to the meninges and fetoplacental unit.[1] The disease 
usually presents as a febrile diarrhoeal illness, but may also cause 
septicaemia, meningitis and chorioamnionitis. Listerial meningitis 
may be the third most common cause of acute community­acquired 
bacterial meningitis.[2]
Listerial brainstem meningitis (LBE), however, is an uncommon, 
sporadically occurring form of listerial infection that progresses 
rapidly and is invariably fatal unless treated early.[3­5] Cases are 
often undetected.[5] It is characterised by a prodromal febrile illness 
followed within 4 ­ 10 days by the abrupt onset of cranial nerve deficits 
associated with encephalopathy, hemiparesis, hemisensory loss and/
or cerebellar signs.[3­5] Unlike the other forms of central nervous 
system (CNS) listeriosis, LBE is striking in respect of the stepwise 
development of brainstem signs in the absence of meningism. This 
presentation is probably accounted for by a novel route of infection 
that exploits retrograde axonal transport to the brainstem along the 
cranial nerves that supply the oropharynx.[2,6]
Methods
We report on six patients with LBE, of whom five were managed or 
co­managed by the neurology unit at Tygerberg Hospital, Western 
Cape, South Africa, during the period January ­ June 2012. Definite 
cases were defined as cases with a compatible clinical syndrome 
(prodrome followed by stepwise neurological deficits due to brainstem 
disease) and microbiological demonstration of L. monocytogenes in 
blood, cerebrospinal fluid (CSF) or brain tissue. Probable cases were 
defined as cases with a compatible clinical syndrome with ancillary 
tests (brain imaging and CSF analysis) supporting the diagnosis 
and evidence of improvement after commencement of antilisterial 
therapy.
The Stellenbosch University Human Research Ethics Committee 
approved the reporting of clinical material (S13/10/223).
Case report
The index case (patient 1) was a 59­year­old woman who presented 
with a 1­week flu­like illness followed by ataxia and sensory loss 
involving the face. Thereafter she developed a deteriorating level of 
consciousness and died within 3 weeks.
At onset she complained of fever, dizziness and unremitting 
frontal headache, and she was treated with telithromycin followed by 
moxifloxacin for suspected sinusitis. One week later, she developed 
hoarseness, numbness of the left cheek and ataxia of the left arm. A 
chest radiograph was normal. Magnetic resonance imaging (MRI) of 
the brain showed signal abnormalities in the pons and left middle 
cerebellar peduncle on fluid­attenuated inversion recovery (FLAIR) 
sequences, with subtle contrast enhancement on T1­weighted images. 
Intravenous (IV) methylprednisolone was given for 3 days for 
a presumptive diagnosis of acute disseminated encephalomyelitis 
(ADEM), during which her condition remained stable and she was 
apyrexial. However, a day later, she developed a fever and became 
comatose, and was found to have bilateral papilloedema. CSF protein 
and glucose levels were normal, and there were 4 polymorpho nuclear 
cells per high­power field on microscopy. A CSF Gram stain was 
negative, and neither the CSF nor initial blood cultures yielded growth 
after 5 days of incubation. Repeat MRI of the brain showed exten sion 
of signal abnormalities into both cerebellar peduncles, the cerebellum 
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and rostrally into the basal ganglia. There 
was no clinical response to treatment with 
IV corticosteroids and acyclovir. Subsequent 
MRI brain imaging revealed progression of 
disease to involve the upper cervical cord, 
brainstem, cerebellum, bilateral basal ganglia 
and rostral left cerebral hemisphere. A repeat 
CSF sample was acellular with normal 
chemistry and microscopy. The patient died 
after 17 days of illness. Blood cultures taken 
on day 15 as well as CSF cultures taken on 
day 17 cultured L. monocytogenes, and at 
autopsy L.  monocytogenes microabscesses 
were confirmed (Fig. 1).
Discussion
We report two definite (patients 1 and 4) 
and four probable cases of LBE. The clinical 
data and ancillary tests are summarised in 
Tables 1 and 2, respectively. LBE typically 
begins with a prodrome of up to 16 days 
(median 4 days),[3,4] with isolated cases 
reported to have prodromes of more than 
a month.[3] In our series, the median time 
before the onset of neurological signs was 
5.5 days. Headache (73%), fever (85%) and 
nausea or vomiting (64%) are the most 
commonly reported early features,[3,4] but 
these were absent in a third of our patients. 
Mental state at admission is often preserved 
(59%).[3] The prodrome is followed by the 
onset of focal signs of lower brainstem 
and cerebellar involvement. Patients fre­
quently present with asymmetrical cranial 
nerve dysfunction (VII, VI, IX, X and 
V, in order of descending frequency).[3­5] 
Untreated patients deteriorate over days 
with new cranial nerve deficits and the 
emergence of ‘crossed’ or bilateral long­
tract signs (hemiparesis more often than 
hemisensory loss), cerebellar signs and/
or encephalopathy. At maximal evolution, 
most patients have combined cranial nerve 
deficits and long­tract signs (81%), and more 
than half have cerebellar signs.[3­5] Cranial 
Fig. 1. Oil-immersion photomicrograph at 
×  1  000 magnification shows Gram-positive 
short intracellular rods.
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nerve involvement is seen in all patients 
at the nadir of the illness. Frequently, non­
contiguous cranial nerve nuclei will be 
affected during the course of the illness; 
for instance, patient 6 had left trigeminal 
sensory involvement, right abducens palsy 
and lower motor neuron facial weakness, 
as well as a left palatal palsy (cranial 
nerve X), indicating multifocal brainstem 
involvement. Respiratory failure due to 
involvement of the medulla may occur early 
and necessitate ventilatory support.[3,5] A 
reduced level of consciousness was present 
in four of the six patients.
The differential diagnosis of brainstem 
enceph alitis varies depending on population 
and geographical region.[7] Broadly, this 
presentation may be due to demyelination 
(e.g. multiple sclerosis, ADEM) or 
autoimmune/inflammatory (e.g. Behçet’s 
dis ease, paraneoplastic), infectious and 
very rarely neoplastic diseases (e.g. lymph ­
oma).[7,8] Infectious causes in adults include 
viruses, such as entero­ and herpesviruses. 
Surprisingly, however, a bacterial infection 
such as listeria is one of the most common 
infectious causes of brainstem encephalitis. 
In an SA setting, tuberculosis and pro­
gressive multifocal leucoencephalopathy due 
to JC virus infection are also important 
considerations in the setting of progressive 
brainstem disease.
With CNS invasion, listeriosis may target 
the meninges resulting in the typical 
clinical picture of acute/subacute bacterial 
meningitis,[2] but unlike other bacteria 
may also target the brain parenchyma and 
specifically the rhombencephalon (pons, 
medulla, cerebellum). In humans, brainstem 
infection occurs in up to 11 ­ 24% of 
patients with CNS listeriosis.[3,5] In LBE, it 
appears that food­borne bacteria invade the 
brainstem by retrograde axonal migration 
along the oropharyngeal cranial nerves.[2] 
A postmortem study of nine human cases 
of LBE revealed brainstem microabscesses 
that were prominently distributed within 
the nuclei, tracts and intraparenchymal 
Table 2. Laboratory, pathology and radiological investigations 
Patient
1 2 3 4 5 6
Inflammatory markers
WCC 13 13.07 6.52 12.17 15.31 9.57
CRP ND 97 86 85 ND ND
CSF            
Cells (PMN, Ly, E) 4, 0, 0 11, 484, 5 66, 21, 6 12, 68, 9 4, 375, 0 0, 60, 0
Protein (g/L) 0.3 0.8 0.69 0.5 0.59 0.63
Glucose (mmol/L) 6.3 6 3.2 2.8 3.3 3.3
L. monocytogenes  
culture
           
Blood Pos (d15) Neg (× 2) Neg (× 2) Pos (× 2) Neg (× 2) Neg (× 2)
CSF Pos (d17) Neg Neg ND Neg Neg
Brain biopsy Pos ND ND ND ND ND
CT ND N Well­defined 
ring lesions 
dorsal Po,  
L MCP
Poorly defined 
lesions  
R Po, R MCP; 
incomplete 
ring 
enhancement
N N
MRI            
 Distribution of high signal on 
T2WI & FLAIR sequences
L Po, MCP, 
and Cb 
L cerebral ped, 
L MCP, L Cb
ND R cerebral ped, 
R MCP, Me, 
upper cord
R cerebral ped, 
R MCP, dorsal 
Po, Me, upper 
cord
Mb, dorsal Po, 
Cb vermis, 
Me; after 9 d 
interval:  
new lesions  
L thalamic,  
L parietal
 Enhancement pattern on T1WI 
pre­/post gadolinium
Subtle, 
incomplete 
ring dorsal Po
Complete ring ND Incomplete 
ring
Patchy, 
nodular
Patchy, 
nodular; 
complete ring
CN enhancement present N Y Y Y N N
Radiological differential reported Demyelination 
(BS/ADEM), 
glioma
Abscess Tuberculoma, 
listerial 
abscess
Demyelination 
(ADEM)
Demyelination 
(ADEM)
Abscess, 
demyelination 
WCC = white cell count; CRP = C­reactive protein; CSF = cerebrospinal fluid; PMN = polymorphonuclear cell; Ly = lymphocyte; E = erythrocyte; CT = computed tomography; MRI = magnetic 
resonance imaging; T2WI = T2­weighted imaging; FLAIR = fluid attenuated inversion recovery; Pos = positive; Neg = negative; d = days since symptom onset; ND = not done; N = normal; L = left; 
R = right; Mb = midbrain; Po = pons; MCP = middle cerebellar peduncle; Cb = cerebellum; Me = medulla; ped = peduncle; CN = cranial nerve; N = no; Y = yes; BS = Bickerstaff encephalitis; 
ADEM = acute disseminated encephalomyelitis.
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portions of the cranial nerves innervating 
the oropharynx (V, VII, IX, X and XII).[9] 
Injection of listerial bacteria into the facial 
nerves of mice was followed 5 ­ 10 days 
later by ipsilateral CNS deficits that were 
prevented by section of the nerve proximal 
to the inoculation site.[10] Similarly, injection 
of listerial bacteria into the sciatic nerves of 
mice resulted in a flaccid paraparesis that 
was prevented by sectioning the sciatic nerve 
proximal to the inoculation site.[10] Actin­
dependent locomotion of L. monocytogenes 
along microtubules has been demonstrated 
in other eukaryote cells and remains the 
most plausible explanation for bacterial 
propagation along axons.[11]
Factors predisposing to LBE in humans 
have not been identified. Unlike listerial 
meningitis, where two­thirds of patients 
are immunosuppressed by medication, 
advanced age or comorbid disease, LBE 
has been reported to occur mainly in 
immunocompetent adults.[3] Of our patients, 
three had comorbid conditions such as 
immunosuppressant therapy, diabetes, 
alcoholism and HIV infection.
Of importance, CSF abnormalities in 
LBE are not typical of bacterial infections 
of the CNS, and one in five patients may 
have normal CSF on initial sampling.[3] A 
relatively normal CSF glucose level, mod erate 
lymphocytic pleocytosis and a moderately 
increased CSF protein level may mistakenly be 
attributed to viral or myco bacterial infection, 
or, as in one of our patients, to inflammatory 
demyelination.[3­5] The CSF was normal in 
one of our patients, and patient 3 had a 
neutrophil­predominant mild pleocytosis.
In a review of patients with LBE by 
Armstrong and Fung,[3] CSF Gram stains 
were positive in only 10% of cases, with 
CSF cultures positive in 33 ­ 41% and blood 
cultures in 61%. Positive cultures were 
obtained in two of our six patients (two on 
blood, one on CSF).
MRI is the radiological investigation 
of choice in the diagnosis of brainstem 
disease. In our series, findings on MRI 
were abnormal in all patients studied 
(five scanned, see example in Fig. 2), and 
showed T2 signal change in the brainstem, 
cerebellar peduncles and cerebellum 
associated with variable enhancement on 
contrasted T1­weighted images. Computed 
tomography (CT) is less sensitive than 
MRI in LBE;[3–5] two of five patients in 
this study had abnormal findings. Striking 
cranial nerve enhancement may be seen 
on MRI,[12] or, less often, on CT, and was 
present in three of our six patients (two 
MRI, one CT). Radiological appearances 
are nonspecific, however, and in a region 
of high tuberculosis prevalence listerial 
brainstem abscesses may be radiologically 
indistinguishable from tuberculomas. In 
the absence of microbiological or histo­
pathological confirmation, empiric treat­
ment for both L. monocytogenes and Myco-
bacterium tuberculosis may have to be 
considered. Rapid radiological and clinical 
improvement would favour listeriosis over 
tuberculosis as the likely cause.
Supratentorial abscess formation may occur 
in conjunction with LBE and was present in 
patients 1 and 6 in our series.[3,13] Follow­
ing the prodrome and initial neurological 
deficit, patient 6 received high­dose cortico­
steroids for a presumed diagnosis of ADEM, 
after which disease progression appeared 
stable until abrupt deterioration on day 35. 
MRI showed left thalamic and parietal lobe 
abscess formation. A biopsy specimen of 
brain tissue for culture, obtained 5 days 
after starting intravenous ampicillin, was 
negative. The patient made a remarkable 
recovery.
High­dose ampicillin is the drug of choice. 
The recommended treatment is ampicillin 
2  g IV 4­hourly for 21 days,[14] although 
some authors suggest longer treatment 
periods and the addition of an amino­
glycoside.[15] Gentamicin acts synergistically 
with ampicillin and may be added in patients 
with immune impairment.[3] Co­trimoxazole 
is an acceptable alternative in penicillin­
allergic patients.[14] It is important to note that 
third­generation cephalosporins, commonly 
recommended as first­line therapy for 
bacterial meningitis of unknown cause, have 
no activity against Listeria species.
Untreated patients invariably die,[3­5] usu­
ally within 5 ­ 18 days after symptom onset.[3] 
Treated survival rates of 49 ­ 64% have been 
reported.[3,4] Early treatment with ampicillin 
is associated with improved survival (76%) 
compared with delayed treatment or initial 
treatment with inappropriate antibiotics 
such as cephalosporins.[3] Neurological 
dysfunction improves within 2 ­ 7 days of 
drug initiation.[4] In our series, no patient 
suffered disabling sequelae.
Small epidemics of listeriosis from contam­
inated food sources are frequently reported in 
countries where the infection is notifiable, and 
the source of the contaminated food has often 
been identified. Given the high fatality rate of 
listeriosis, contaminated food is an important 
public health hazard. In SA, however, the 
disease is not notifiable at present. It is of 
interest that, as three patients in this series 
presented within 6 months of each other and 
came from geographically closely related areas, 
the infection may have been caused by a 
common contaminated food source.
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Fig. 2. Sagittal MRI brain scan (T1WI post 
gadolinium) of patient 4 showing rim-enhancing 
lesions in the brainstem. (MRI = magnetic 
resonance imaging.)
